ニキビ治療薬の世界市場 2023-2027

当レポートでは、ニキビ治療薬市場をモニターしており、2022年から2027年の間に9億711万米ドル、予測期間中のCAGRは3.46%で成長すると予測しています。

当レポートでは、ニキビ治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新の動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、診断方法の改善、新しいニキビ治療薬の登場、にきびの症例の増加によって牽引されています。

本調査では、今後数年間のニキビ治療薬市場の成長を促進する主要な理由の一つとして、皮膚科疾患に対する遺伝子治療に関する研究の増加を挙げています。また、ベンダーによる無機的な成長戦略や、にきび治療におけるイノベーションが、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場別分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• ニキビ治療薬の世界市場 2017-2021
• タイプセグメント分析 2017-2021
• 投与経路セグメント分析 2017-2021
• 地域別分析 2017-2021
• 国別分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 処方薬：市場規模と予測 2022-2027
• 一般用医薬品：市場規模と予測 2022-2027
• 市場機会：タイプ別

第7章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• 話題の：市場規模と予測 2022-2027
• オーラル：市場規模と予測 2022-2027
• 市場機会：投与経路別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 日本：市場規模と予測 2022-2027
• 市場機会：地域別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AndroScience Corp.
• Astellas Pharma Inc.
• Bayer AG
• Cipher Pharmaceuticals Inc.
• Cosmo Pharmaceuticals NV
• Elorac Inc.
• Equalan Pharma Europe Sp. z o.o.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Johnson and Johnson Services Inc.
• Journey Medical Corp.
• Paratek Pharmaceuticals Inc.
• Photocure ASA
• Timber Pharmaceuticals LLC
• Viatris Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global acne drugs market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Type - Market share 2022-2027 (%)
• Exhibits31: Data Table on Type - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibits45: Data Table on Route of Administration - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Route of Administration
• Exhibits47: Data Table on Comparison by Route of Administration
• Exhibits48: Chart on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Topical - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Topical - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Oral - Year-over-year growth 2022-2027 (%)
• Exhibits56: Market opportunity by Route of Administration ($ million)
• Exhibits57: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share by geography 2022-2027 (%)
• Exhibits60: Data Table on Market share by geography 2022-2027 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits99: Market opportunity by geography ($ million)
• Exhibits100: Data Tables on Market opportunity by geography ($ million)
• Exhibits101: Impact of drivers and challenges in 2022 and 2027
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: AndroScience Corp. - Overview
• Exhibits108: AndroScience Corp. - Product / Service
• Exhibits109: AndroScience Corp. - Key offerings
• Exhibits110: Astellas Pharma Inc. - Overview
• Exhibits111: Astellas Pharma Inc. - Product / Service
• Exhibits112: Astellas Pharma Inc. - Key news
• Exhibits113: Astellas Pharma Inc. - Key offerings
• Exhibits114: Bayer AG - Overview
• Exhibits115: Bayer AG - Business segments
• Exhibits116: Bayer AG - Key news
• Exhibits117: Bayer AG - Key offerings
• Exhibits118: Bayer AG - Segment focus
• Exhibits119: Cipher Pharmaceuticals Inc. - Overview
• Exhibits120: Cipher Pharmaceuticals Inc. - Business segments
• Exhibits121: Cipher Pharmaceuticals Inc. - Key offerings
• Exhibits122: Cipher Pharmaceuticals Inc. - Segment focus
• Exhibits123: Cosmo Pharmaceuticals NV - Overview
• Exhibits124: Cosmo Pharmaceuticals NV - Product / Service
• Exhibits125: Cosmo Pharmaceuticals NV - Key news
• Exhibits126: Cosmo Pharmaceuticals NV - Key offerings
• Exhibits127: Elorac Inc. - Overview
• Exhibits128: Elorac Inc. - Product / Service
• Exhibits129: Elorac Inc. - Key offerings
• Exhibits130: Equalan Pharma Europe Sp. z o.o. - Overview
• Exhibits131: Equalan Pharma Europe Sp. z o.o. - Product / Service
• Exhibits132: Equalan Pharma Europe Sp. z o.o. - Key offerings
• Exhibits133: F. Hoffmann La Roche Ltd. - Overview
• Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits135: F. Hoffmann La Roche Ltd. - Key news
• Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits138: GlaxoSmithKline Plc - Overview
• Exhibits139: GlaxoSmithKline Plc - Business segments
• Exhibits140: GlaxoSmithKline Plc - Key news
• Exhibits141: GlaxoSmithKline Plc - Key offerings
• Exhibits142: GlaxoSmithKline Plc - Segment focus
• Exhibits143: Johnson and Johnson Services Inc. - Overview
• Exhibits144: Johnson and Johnson Services Inc. - Business segments
• Exhibits145: Johnson and Johnson Services Inc. - Key news
• Exhibits146: Johnson and Johnson Services Inc. - Key offerings
• Exhibits147: Johnson and Johnson Services Inc. - Segment focus
• Exhibits148: Journey Medical Corp. - Overview
• Exhibits149: Journey Medical Corp. - Product / Service
• Exhibits150: Journey Medical Corp. - Key offerings
• Exhibits151: Paratek Pharmaceuticals Inc. - Overview
• Exhibits152: Paratek Pharmaceuticals Inc. - Product / Service
• Exhibits153: Paratek Pharmaceuticals Inc. - Key offerings
• Exhibits154: Photocure ASA - Overview
• Exhibits155: Photocure ASA - Product / Service
• Exhibits156: Photocure ASA - Key offerings
• Exhibits157: Timber Pharmaceuticals LLC - Overview
• Exhibits158: Timber Pharmaceuticals LLC - Product / Service
• Exhibits159: Timber Pharmaceuticals LLC - Key offerings
• Exhibits160: Viatris Inc. - Overview
• Exhibits161: Viatris Inc. - Business segments
• Exhibits162: Viatris Inc. - Key offerings
• Exhibits163: Viatris Inc. - Segment focus
• Exhibits164: Inclusions checklist
• Exhibits165: Exclusions checklist
• Exhibits166: Currency conversion rates for US$
• Exhibits167: Research methodology
• Exhibits168: Validation techniques employed for market sizing
• Exhibits169: Information sources
• Exhibits170: List of abbreviations

Technavio has been monitoring the acne drugs market and is forecast to grow by $907.11 mn during 2022-2027, accelerating at a CAGR of 3.46% during the forecast period. Our report on the acne drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the emergence of improved diagnostic modalities, the launch of new acne drugs, and increasing cases of acne.

Technavio's acne drugs market is segmented as below:

By Type

• Prescription drugs
• OTC drugs

By Route Of Administration

• Topical
• Oral

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing research on gene therapy for dermatologic conditions as one of the prime reasons driving the acne drugs market growth during the next few years. Also, inorganic growth strategies by vendors and innovation in acne treatment will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the acne drugs market covers the following areas:

• Acne drugs market sizing
• Acne drugs market forecast
• Acne drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading acne drugs market vendors that include AndroScience Corp., Astellas Pharma Inc., Bayer AG, Cipher Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Elorac Inc., Equalan Pharma Europe Sp. z o.o., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Journey Medical Corp., McKesson Corp., Paratek Pharmaceuticals Inc., Photocure ASA, Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Timber Pharmaceuticals LLC, Viatris Inc., and XBiotech Inc. Also, the acne drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global acne drugs market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global acne drugs market 2017 - 2021 ($ million)
• 4.2 Type Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.3 Route of administration Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Prescription drugs - Market size and forecast 2022-2027
• Exhibit 34: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
• 6.4 OTC drugs - Market size and forecast 2022-2027
• Exhibit 38: Chart on OTC drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Route of Administration

• 7.1 Market segments
• Exhibit 44: Chart on Route of Administration - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Route of Administration - Market share 2022-2027 (%)
• 7.2 Comparison by Route of Administration
• Exhibit 46: Chart on Comparison by Route of Administration
• Exhibit 47: Data Table on Comparison by Route of Administration
• 7.3 Topical - Market size and forecast 2022-2027
• Exhibit 48: Chart on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Topical - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Topical - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Topical - Year-over-year growth 2022-2027 (%)
• 7.4 Oral - Market size and forecast 2022-2027
• Exhibit 52: Chart on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Oral - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Oral - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Route of Administration
• Exhibit 56: Market opportunity by Route of Administration ($ million)
• Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share by geography 2022-2027 (%)
• Exhibit 60: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity by geography
• Exhibit 99: Market opportunity by geography ($ million)
• Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 AndroScience Corp.
• Exhibit 107: AndroScience Corp. - Overview
• Exhibit 108: AndroScience Corp. - Product / Service
• Exhibit 109: AndroScience Corp. - Key offerings
• 12.4 Astellas Pharma Inc.
• Exhibit 110: Astellas Pharma Inc. - Overview
• Exhibit 111: Astellas Pharma Inc. - Product / Service
• Exhibit 112: Astellas Pharma Inc. - Key news
• Exhibit 113: Astellas Pharma Inc. - Key offerings
• 12.5 Bayer AG
• Exhibit 114: Bayer AG - Overview
• Exhibit 115: Bayer AG - Business segments
• Exhibit 116: Bayer AG - Key news
• Exhibit 117: Bayer AG - Key offerings
• Exhibit 118: Bayer AG - Segment focus
• 12.6 Cipher Pharmaceuticals Inc.
• Exhibit 119: Cipher Pharmaceuticals Inc. - Overview
• Exhibit 120: Cipher Pharmaceuticals Inc. - Business segments
• Exhibit 121: Cipher Pharmaceuticals Inc. - Key offerings
• Exhibit 122: Cipher Pharmaceuticals Inc. - Segment focus
• 12.7 Cosmo Pharmaceuticals NV
• Exhibit 123: Cosmo Pharmaceuticals NV - Overview
• Exhibit 124: Cosmo Pharmaceuticals NV - Product / Service
• Exhibit 125: Cosmo Pharmaceuticals NV - Key news
• Exhibit 126: Cosmo Pharmaceuticals NV - Key offerings
• 12.8 Elorac Inc.
• Exhibit 127: Elorac Inc. - Overview
• Exhibit 128: Elorac Inc. - Product / Service
• Exhibit 129: Elorac Inc. - Key offerings
• 12.9 Equalan Pharma Europe Sp. z o.o.
• Exhibit 130: Equalan Pharma Europe Sp. z o.o. - Overview
• Exhibit 131: Equalan Pharma Europe Sp. z o.o. - Product / Service
• Exhibit 132: Equalan Pharma Europe Sp. z o.o. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 GlaxoSmithKline Plc
• Exhibit 138: GlaxoSmithKline Plc - Overview
• Exhibit 139: GlaxoSmithKline Plc - Business segments
• Exhibit 140: GlaxoSmithKline Plc - Key news
• Exhibit 141: GlaxoSmithKline Plc - Key offerings
• Exhibit 142: GlaxoSmithKline Plc - Segment focus
• 12.12 Johnson and Johnson Services Inc.
• Exhibit 143: Johnson and Johnson Services Inc. - Overview
• Exhibit 144: Johnson and Johnson Services Inc. - Business segments
• Exhibit 145: Johnson and Johnson Services Inc. - Key news
• Exhibit 146: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 147: Johnson and Johnson Services Inc. - Segment focus
• 12.13 Journey Medical Corp.
• Exhibit 148: Journey Medical Corp. - Overview
• Exhibit 149: Journey Medical Corp. - Product / Service
• Exhibit 150: Journey Medical Corp. - Key offerings
• 12.14 Paratek Pharmaceuticals Inc.
• Exhibit 151: Paratek Pharmaceuticals Inc. - Overview
• Exhibit 152: Paratek Pharmaceuticals Inc. - Product / Service
• Exhibit 153: Paratek Pharmaceuticals Inc. - Key offerings
• 12.15 Photocure ASA
• Exhibit 154: Photocure ASA - Overview
• Exhibit 155: Photocure ASA - Product / Service
• Exhibit 156: Photocure ASA - Key offerings
• 12.16 Timber Pharmaceuticals LLC
• Exhibit 157: Timber Pharmaceuticals LLC - Overview
• Exhibit 158: Timber Pharmaceuticals LLC - Product / Service
• Exhibit 159: Timber Pharmaceuticals LLC - Key offerings
• 12.17 Viatris Inc.
• Exhibit 160: Viatris Inc. - Overview
• Exhibit 161: Viatris Inc. - Business segments
• Exhibit 162: Viatris Inc. - Key offerings
• Exhibit 163: Viatris Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 164: Inclusions checklist
• Exhibit 165: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 166: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 167: Research methodology
• Exhibit 168: Validation techniques employed for market sizing
• Exhibit 169: Information sources
• 13.5 List of abbreviations
• Exhibit 170: List of abbreviations